BRIEF-UCB and Amgen seek marketing approval of romosozumab in Japan
December 20, 2016 at 01:14 AM EST
* Says Amgen and UCB announce submission of application for investigational osteoporosis medication romosozumab in Japan
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|